AstraZeneca Moves To Fend Off Generic Seroquel
In an attempt to stave off the launch of a generic copy of its top-selling anti-psychotic drug Seroquel, AstraZeneca Pharmaceuticals LP has asked a federal court for permission to file a...To view the full article, register now.
Already a subscriber? Click here to view full article